• Sign In
  • My Marketwire Account
  • Marketwire Resonate
  • News Dashboard 2.0
  • Mediahub
  • Personal Beat
  • Hot Off the Wire
• Register
• Français
• Marketwired Blog
• Careers
• Contact Marketwired

Browse By:

• Industry
  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals
  • Computers and Software
  • Education and Training
  • Electronics and Semiconductors
  • Energy and Utilities
  • Environment
  • Financial Services
  • Food and Beverage
  • Government
  • Lifestyle and Leisure
  • Manufacturing and Production
  • Media and Entertainment
  • Medical and Healthcare
  • Pharmaceuticals and Biotech
  • Professional Services
  • Real Estate and Construction
  • Retail
  • Sports
  • Telecom
  • Transportation and Logistics
  • Travel and Hospitality
• Topic
  • Associations
  • Bankruptcy
  • Class action
  • Conference calls
  • Dividends
  • Earnings
  • Earnings projections
  • Financing agreements
  • Initial public offerings
  • Investment opinion
  • Management changes
  • Media advisory
  • Mergers and acquisitions
  • Special news events
  • Stock splits
  • Stock/other market news
  • Trade shows
  • Webcasts
• Type
  • News Releases
  • Media Advisories
  • Feature Packs
  • Webcasts
  • Social Media 2.0

News Room: Drugs

Xylitol Canada Inc. Financial Results for Three Months Ended March 31, 2013
TORONTO, ONTARIO--(Marketwired - May 17, 2013) - Xylitol Canada Inc. ("Xylitol Canada", or the "Company") (TSX VENTURE:XYL) today announces that it has released its financial and...(more)
Xylitol Canada Inc.  
May 17, 2013 16:51 ET
 

 

Aeolus Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry Veterans
MISSION VIEJO, CA--(Marketwired - May 17, 2013) -  Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...(more)
Aeolus Pharmaceuticals  
May 17, 2013 14:19 ET
 

 

Biologix Hair Inc. Appoints Mark Maybank to its Board of Directors
TORONTO, ONTARIO--(Marketwired - May 17, 2013) - Biologix Hair Inc. (OTCBB:BLGX) (OTCQB:BLGX) has appointed Mark Maybank to the Company's Board of Directors. Mr. Maybank will serve as...(more)
Biologix Hair Inc.  
May 17, 2013 09:38 ET
 

 

Prima BioMed Issues the Following Notice to Stockholders of the Company
SYDNEY, AUSTRALIA--(Marketwired - May 16, 2013) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") has announced in pursuant to shareholder approval...(more)
Prima BioMed  
May 16, 2013 22:35 ET
 

 

Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013
HALIFAX, NOVA SCOTIA--(Marketwired - May 16, 2013) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today released its financial and...(more)
Immunovaccine Inc.  
May 16, 2013 17:05 ET
 

 

Rockwell Medical Announces the Exercise of Over-Allotment Option
WIXOM, MI--(Marketwired - May 16, 2013) - Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease ...(more)
Rockwell Medical Technologies, Inc.  
May 16, 2013 16:30 ET
 

 

Paladin présentera à la conférence de Bloom Burton à Toronto
MONTRÉAL, CANADA--(Marketwired - 16 mai 2013) - Laboratoires Paladin Inc. (TSX:PLB), chef de file de l'industrie pharmaceutique spécialisée au Canada, a annoncé aujourd'hui que son...(more)
Laboratoires Paladin Inc.  
May 16, 2013 16:02 ET
 

 

Paladin Labs to Present at the Bloom Burton & Co. Healthcare Investor Conference in Toronto
MONTREAL, CANADA--(Marketwired - May 16, 2013) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, announced today that Mr. Mark Beaudet, interim...(more)
Paladin Labs Inc.  
May 16, 2013 16:02 ET
 

 

SciClone Reports Anticipated Financial Results for the First Quarter 2013
FOSTER CITY, CA--(Marketwired - May 16, 2013) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported its expectations regarding financial results for the quarter ended March 31, 2013. ...(more)
SciClone Pharmaceuticals, Inc.  
May 16, 2013 16:00 ET
 

 

SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market
FOSTER CITY, CA--(Marketwired - May 16, 2013) -  SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company has entered into an agreement with Zensun (Shanghai) Science...(more)
SciClone Pharmaceuticals, Inc.  
May 16, 2013 16:00 ET